Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. (Q54198879)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. |
scientific article |
Statements
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. (English)
1 reference
W H Wilson
1 reference
S Bates
1 reference
A Fojo
1 reference
J O'Shaughnessy
1 reference
S L Berg
1 reference
G Bryant
1 reference
R E Wittes
1 reference
S M Steinberg
1 reference
B R Goldspiel
1 reference
J Herdt
1 reference
1 August 1994
1 reference
12
1 reference
8
1 reference
1621-1629
1 reference